ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0748

Mapping Long COVID-19 Patient Journeys for Rheumatic Disease Patients

Yomei Shaw1, Beth Wallace2, Hallie Chabrier3, Charlotte Cochrane3, Christina Kim3, Katherine Taylor3, Armaan Patel3, Nima Keyvan4, Vinayak Swaroop3, Nina Nguyen3, Sara Hustek5, Meriah Moore4, Andrew Admon4 and Kaleb Michaud6, 1FORWARD, The National Databank for Rheumatic Diseases, Santa Fe, NM, 2Michigan Medicine, VA Ann Arbor Healthcare System, Ann Arbor, MI, 3University of Michigan Division of Rheumatology, Ann Arbor, MI, 4University of Michigan, Ann Arbor, MI, 5University of Michigan Division of Rheumatology, Mount Clemens, MI, 6University of Nebraska Medical Center, Omaha, NE

Meeting: ACR Convergence 2022

Keywords: COVID-19, Health Services Research

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Health Services Research Poster II

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: One-third of individuals who contract COVID-19 develop ‘long COVID’ symptoms that persist after their initial illness. Long COVID can cause fatigue, chronic pain, and respiratory and neurological issues that impair physical function and reduce quality of life. Characterization of existing care patterns among long COVID patients is needed to inform development of long COVID care services. Underlying health conditions like rheumatic diseases (RDs) increase long COVID risk, with 37% of RD patients reporting consistent symptoms at 6 months. As long COVID symptoms often overlap with RD symptoms, diagnosing and managing long COVID in this population poses unique challenges. We aimed to describe care pathways and care coordination challenges for patients with rheumatic diseases and long COVID.

Methods: We used electronic medical record (EMR) review to identify 16 rheumatology patients at our institution demonstrating symptoms consistent with long-COVID ≥3 months after a confirmed COVID-19 diagnosis. The study team closely read the EMR documents and created patient journey maps summarizing health status, interactions with health care providers, treatments, and decision making over time. We assessed severity of symptoms thought to be associated with COVID-19 using the WHO Clinical Progression Scale (CPS) during hospitalizations and the Post COVID Functional Status (PCFS) scale at other times, and changes in health status over time were visually represented based on changes in the CPS and PCFS on the patient journey maps. Care coordination challenges were documented and described.

Results: Patient characteristics are shown in Table 1. An excerpt from a patient journey map is shown in Figure 1. Three patients were not hospitalized (PCFS 0-3), 9 were hospitalized within 2 weeks of symptom onset (PCFS 0-4, CPS 4-9), and 4 were hospitalized >= 2 weeks after symptom onset (PCFS 0-3, CPS 4-5). Of the 13 hospitalized patients, 3 were readmitted at least once over the next 8 months. Patients often experienced alternating periods of symptom improvement and worsening.

We identified five categories of care coordination issues (Table 2): disease flares/DMARD management, work-related issues, access to care, patient requests for COVID-19-related treatments/procedures, and patient need for reassurance/information.

Conclusion: Among patients with rheumatic disease, cases of long COVID demonstrated variable trajectories and disrupted patients’ functioning and ability to work. In addition to addressing long COVID symptoms, patients relied on assistance from health care providers to submit requests for work leave/return to work. The care coordination issues identified remain broadly relevant at this point in the pandemic, and can be used to establish priorities for research/policy around long COVID both for patients with RMDs and other chronic illnesses.

Supporting image 1

Table 1. Subject characteristics (n=16)

Supporting image 2

Table 2. Care coordination issues

Supporting image 3

Figure 1. Excerpt of long COVID patient journey map for ‘Sabrina’ (pseudonym), a lupus patient in her 40s who works full time (not hospitalized)


Disclosures: Y. Shaw, None; B. Wallace, None; H. Chabrier, None; C. Cochrane, None; C. Kim, None; K. Taylor, None; A. Patel, None; N. Keyvan, None; V. Swaroop, None; N. Nguyen, None; S. Hustek, None; M. Moore, None; A. Admon, None; K. Michaud, None.

To cite this abstract in AMA style:

Shaw Y, Wallace B, Chabrier H, Cochrane C, Kim C, Taylor K, Patel A, Keyvan N, Swaroop V, Nguyen N, Hustek S, Moore M, Admon A, Michaud K. Mapping Long COVID-19 Patient Journeys for Rheumatic Disease Patients [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/mapping-long-covid-19-patient-journeys-for-rheumatic-disease-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mapping-long-covid-19-patient-journeys-for-rheumatic-disease-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology